Diagnostic Criteria Schemes for Multicentric Castleman Disease in 75 Cases
Authors:
- Mark BowerMBMark Bower
- Alessia Dalla Mbbs PriaAPAlessia Dalla Mbbs Pria
- Christopher Mbbs CoyleCCChristopher Mbbs Coyle
- Kikkeri Mbbs NareshKikkeri Mbbs Naresh
- 1 February 2014
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 65 (2) , e80-e82
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman diseaseCurrent Opinion in Oncology, 2012
- Clinical Features and Outcome in HIV-Associated Multicentric Castleman's DiseaseJournal of Clinical Oncology, 2011
- Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disordersJournal of Clinical Pathology, 2007
- Prospective Study of Rituximab in Chemotherapy-Dependent Human Immunodeficiency Virus–Associated Multicentric Castleman's Disease: ANRS 117 CastlemaB TrialJournal of Clinical Oncology, 2007
- Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV‐8)‐positive multicentric Castleman's disease and featuring a follicular growth patternAPMIS, 2007
- HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8–positive plasmablastic lymphomaBlood, 2000